Therefore, researchers found that inhibition of autophagy further reduced sorafenib sensitivity in sorafenib-resistant HCC cells, and conversely, inhibition of Akt induced a switch of autophagy from cytoprotective to pro-death mechanisms, thereby reversing acquired resistance to sorafenib (Neophytou et al., 2021). Here, AKT1 is linked to hepatocellular carcinoma.